HER2 Testing Trends and Forecast
The future of the global HER2 testing market looks promising with opportunities in the hospitals and diagnostic laboratories markets. The global HER2 testing market is expected to grow with a CAGR of 7.1% from 2024 to 2030. The major drivers for this market are increasing significance of personalized medical approaches and surge in the prevalence of breast and gastric cancers.A more than 150-page report is developed to help in your business decisions.
HER2 Testing by Segment
The study includes a forecast for the global HER2 testing by technique, cancer type, end use, and region.HER2 Testing Market by Technique [Shipment Analysis by Value from 2018 to 2030]:
- Fluorescence In Situ Hybridization
- Dual-Probe
- Single-Probe
- Chromogenic In Situ Hybridization
- Silver-Enhanced In Situ Hybridization
HER2 Testing Market by Cancer Type [Shipment Analysis by Value from 2018 to 2030]:
- Breast Cancer
- Gastric Cancer
HER2 Testing Market by End Use [Shipment Analysis by Value from 2018 to 2030]:
- Hospitals
- Diagnostic Laboratories
- Others
HER2 Testing Market by Region [Shipment Analysis by Value from 2018 to 2030]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of HER2 Testing Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies HER2 testing companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the HER2 testing companies profiled in this report include:- Abbott
- Hoffmann-La Roche
- Agilent Technologies
- Thermo Fisher Scientific
- Leica Biosystems
- Empire Genomics
- Bio-Genex Laboratories
HER2 Testing Market Insights
The publisher forecasts that fluorescence in situ hybridization will remain the largest segment over the forecast period due to their cost-effectiveness and faster turnaround times.Within this market, hospitals will remain the largest segment due to availability of specialized medical equipment and infrastructure.
North America will remain the largest region over the forecast period due to high prevalence of breast cancer.
Features of the Global HER2 Testing Market
- Market Size Estimates: HER2 testing market size estimation in terms of value ($B).
- Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
- Segmentation Analysis: HER2 testing market size by technique, cancer type, end use, and region in terms of value ($B).
- Regional Analysis: HER2 testing market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different techniques, cancer types, end uses, and regions for the HER2 testing market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the HER2 testing market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for HER2 testing market?Answer: The global HER2 testing market is expected to grow with a CAGR of 7.1% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the HER2 testing market?
Answer: The major drivers for this market are increasing significance of personalized medical approaches and surge in the prevalence of breast and gastric cancers.
Q3. What are the major segments for HER2 testing market?
Answer: The future of the HER2 testing market looks promising with opportunities in the hospitals and diagnostic laboratories markets.
Q4. Who are the key HER2 testing market companies?
Answer: Some of the key HER2 testing companies are as follows:
- Abbott
- Hoffmann-La Roche
- Agilent Technologies
- Thermo Fisher Scientific
- Leica Biosystems
- Empire Genomics
- Bio-Genex Laboratories
Answer: The publisher forecasts that fluorescence in situ hybridization will remain the largest segment over the forecast period due to their cost-effectiveness and faster turnaround times.
Q6. In HER2 testing market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to high prevalence of breast cancer.
Q7. Do we receive customization in this report?
Answer: Yes, the publisher provides 10% customization without any additional cost.
This report answers the following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the HER2 testing market by technique (fluorescence in situ hybridization, dual-probe, single-probe, chromogenic in situ hybridization, and silver-enhanced in situ hybridization), cancer type (breast cancer and gastric cancer), end use (hospitals, diagnostic laboratories, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Global HER2 Testing Market : Market Dynamics
3. Market Trends and Forecast Analysis from 2018 to 2030
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
5. Competitor Analysis
6. Growth Opportunities and Strategic Analysis
7. Company Profiles of Leading Players
Companies Mentioned
- Abbott
- Hoffmann-La Roche
- Agilent Technologies
- Thermo Fisher Scientific
- Leica Biosystems
- Empire Genomics
- Bio-Genex Laboratories
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.
LOADING...
